Fri, February 14, 2025
[ Fri, Feb 14th ]: WOPRAI
As of Feb 14th, 2025, there has been substantial .. ing of Blockchain Loyalty Corp. in recent trading
[ Fri, Feb 14th ]: WOPRAI
As of Feb 14th, 2025, there has been substantial selling of in recent trading
[ Fri, Feb 14th ]: WOPRAI
As of Feb 14th, 2025, there has been substantial selling of RF Acquisition Corp. in recent trading
[ Fri, Feb 14th ]: WOPRAI
52 Earnings Releases for Feb 14th, 2025
[ Fri, Feb 14th ]: MSN
Warren Buffett: Saving and Investing Tips for Retirees
[ Fri, Feb 14th ]: Investing
Baidu to make next-gen Ernie AI model open-source amid DeepSeek shakeup
Thu, February 13, 2025
[ Thu, Feb 13th ]: MSN
The Best Stocks to Invest $25,000 in Right Now
[ Thu, Feb 13th ]: MSN
Why did the AMP share price just crash more than 13%?
[ Thu, Feb 13th ]: MSN
You thought Magnificent 7 and tech stocks were th .. could be an under-the-radar winner, say analysts
[ Thu, Feb 13th ]: Kiplinger
Stock Market Today: Stocks Pop on Time-Delayed Tariffs
[ Thu, Feb 13th ]: MSN
Jim Cramer Says Jefferies Financial Group Inc. (JEF) 'Had A Surprisingly Bad Quarter'
[ Thu, Feb 13th ]: MSN
What Is a Bond? A Beginner's Guide to How Bonds Work
[ Thu, Feb 13th ]: MSN
The $85 billion ASX 200 gold stock trading at a 35% discount
[ Thu, Feb 13th ]: MSN
I would follow Warren Buffett's advice and buy high-quality ASX shares at fair prices
[ Thu, Feb 13th ]: MSN
10 Best Solar Stocks To Invest In Today
[ Thu, Feb 13th ]: Kiplinger
The Trade Desk Stock Plunges on Soft Revenue, Weak Outlook
BenQ Lighting
[ Thu, Feb 13th ]: MSN
Corcept Therapeutics stock soars to all-time high of $71.3
[ Thu, Feb 13th ]: MSN
Jim Cramer Says He's 'Worried' About The Wendy's Company (WEN)
[ Thu, Feb 13th ]: MSN
Jim Cramer on TETRA Technologies, Inc. (TTI): 'It .. Very Good Company. It Did Come Up From The Ashes'
[ Thu, Feb 13th ]: MSN
Jim Cramer on Abbott Laboratories (ABT): 'Big Position For The Trust'
[ Thu, Feb 13th ]: MSN
Jim Cramer on The Hershey Company (HSY): 'Wake Me .. Times Earnings And Then I Might Even Consider It'
[ Thu, Feb 13th ]: MSN
Brokers Suggest Investing in Blue Bird (BLBD): Read This Before Placing a Bet
[ Thu, Feb 13th ]: MSN
JPM highlights potential tariff impact on Brazil, India stocks
[ Thu, Feb 13th ]: WOPRAI
Short squeeze is starting in shares of IVDN at $0.3, after crossing above the $0.277 Trigger Price
[ Thu, Feb 13th ]: WOPRAI
Short squeeze is starting in shares of EVER at $2 .. 5, after crossing above the $21.348 Trigger Price
[ Thu, Feb 13th ]: WOPRAI
Short squeeze is starting in shares of EEFT at $1 .. , after crossing above the $107.389 Trigger Price
[ Thu, Feb 13th ]: WOPRAI
Short squeeze is starting in shares of DPG at $11 .. 9, after crossing above the $11.819 Trigger Price
[ Thu, Feb 13th ]: WOPRAI
Short squeeze is starting in shares of CROX at $1 .. 6, after crossing above the $97.922 Trigger Price
[ Thu, Feb 13th ]: WOPRAI
Short squeeze is starting in shares of AVNT at $4 .. 4, after crossing above the $41.989 Trigger Price
[ Thu, Feb 13th ]: WOPRAI
Short squeeze is starting in shares of ATLCY at $ .. 2, after crossing above the $15.352 Trigger Price
[ Thu, Feb 13th ]: WOPRAI
Short squeeze is starting in shares of ANCTF at $ .. 8, after crossing above the $50.826 Trigger Price
[ Thu, Feb 13th ]: WOPRAI
Short squeeze is starting in shares of ADYEY at $ .. 5, after crossing above the $17.373 Trigger Price
[ Thu, Feb 13th ]: MSN
Jim Cramer on Nu Holdings Ltd. (NU): 'It's Very Expensive'
[ Thu, Feb 13th ]: Kiplinger
Reddit Stock Falls After User Number Disappoints
[ Thu, Feb 13th ]: Kiplinger
Why Robinhood Stock Is Soaring After Earnings
[ Thu, Feb 13th ]: WOPRAI
Short squeeze is starting in shares of STGW at $6 .. 85, after crossing above the $6.398 Trigger Price
[ Thu, Feb 13th ]: WOPRAI
Short squeeze is starting in shares of PDFS at $2 .. 4, after crossing above the $27.661 Trigger Price
[ Thu, Feb 13th ]: WOPRAI
Short squeeze is starting in shares of MDV at $15 .. 3, after crossing above the $15.291 Trigger Price
[ Thu, Feb 13th ]: WOPRAI
Short squeeze is starting in shares of TNA at $43 .. 4, after crossing above the $42.993 Trigger Price
[ Thu, Feb 13th ]: WOPRAI
Short squeeze is starting in shares of CZR at $37 .. 7, after crossing above the $37.114 Trigger Price
[ Thu, Feb 13th ]: WOPRAI
Short squeeze is starting in shares of CUBE at $4 .. 8, after crossing above the $42.064 Trigger Price
[ Thu, Feb 13th ]: WOPRAI
Short squeeze is starting in shares of CEVA at $3 .. 5, after crossing above the $34.925 Trigger Price
[ Thu, Feb 13th ]: MSN
Kraft Heinz cut by BofA and Citi as outlook disappoints
[ Thu, Feb 13th ]: MSN
Jim Cramer on Rockwell Automation, Inc. (ROK): 'I .. ted In How Much They're Really Doing In Robotics'
[ Thu, Feb 13th ]: Investing
FTSE 100 Live: Shares in Barclays, BAT and Unilever tumble under bond pressure
[ Thu, Feb 13th ]: WOPRAI
Short squeeze is starting in shares of WSTG at $1 .. 23, after crossing above the $25.23 Trigger Price
[ Thu, Feb 13th ]: WOPRAI
Short squeeze is starting in shares of WISH at $7 .. 15, after crossing above the $5.596 Trigger Price
[ Thu, Feb 13th ]: WOPRAI
Short squeeze is starting in shares of VVI at $41 .. 6, after crossing above the $30.193 Trigger Price

Corcept Therapeutics stock soars to all-time high of $71.3

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. eutics-stock-soars-to-all-time-high-of-71-3.html
  Print publication without navigation Published in Stocks and Investing on by MSN
          🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source
Corcept Therapeutics Incorporated (NASDAQ:CORT) has reached an unprecedented milestone as its stock price soared to an all-time high of $71.3. According to InvestingPro data, the company maintains a "GREAT" financial health score and has achieved impressive revenue growth of ~40% over the last twelve months.
Corcept Therapeutics Inc.'s stock surged to an all-time high of $71.30, driven by positive developments in its clinical trials and market expansion. The company, known for its focus on treatments for severe metabolic, oncologic, and psychiatric disorders, announced promising results from its ongoing studies, particularly for its lead drug, Korlym, used in treating Cushing's syndrome. Additionally, Corcept has been expanding its research into new indications for Korlym and other pipeline drugs, which has bolstered investor confidence. The stock's rise reflects not only the company's strong performance but also the growing market interest in specialized pharmaceuticals addressing unmet medical needs.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/money/top-stocks/corcept-therapeutics-stock-soars-to-all-time-high-of-71-3/ar-AA1yZsEt ]